News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 2780
- Sources here
- 15
- Companies here
- 32
Active search
2780 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Jim Cramer Reevaluates Novo Nordisk (NVO) as Wegovy Pill Adoption Accelerates
Shares of Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) experienced sharp volatility following its latest quarterly results. On the August 12 episode of Mad Money, Jim Cramer pointed out the disconnect between the company's strong performance and Wall Street's initial negative knee-jerk reaction. Cramer …
Innoviz Technologies (INVZ) seeks reverse split authority and director votes amid Nasdaq notice
Innoviz Technologies (INVZ) will hold an annual general meeting on September 16, 2026, where shareholders will vote on re-electing several Class II and Class III directors. A key proposal seeks authorization for the board to implement a reverse share split at a ratio between …
SS Innovations CEO Sudhir Srivastava Gifts 10,000 Shares of Common Stock
Sudhir Srivastava, Chairman and CEO of SS Innovations International, Inc. (NASDAQ:SSII), reported a gift of 10,000 shares of the company's common stock on August 14, 2026. This transaction was executed at no cost, and following the gift, Srivastava indirectly holds over 108 million shares …
Enova International (ENVA) boosts $300M facility and prices $300.9M consumer loan ABS
Enova International, through its indirect subsidiary NC LOC 2024, has increased its revolving credit facility to $300 million from $200 million, extended its term, and reduced the borrowing rate. Additionally, another indirect subsidiary, NetCredit Combined Receivables B, LLC, priced $300.9 million in asset-backed notes, …
Annovis Bio (NYSE:ANVS) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS
Annovis Bio reported a Q2 2026 EPS of $(0.40), exceeding the analyst estimate of $(0.45), despite widening its net loss to $14.8 million primarily due to a 131% increase in R&D expenses. The company achieved full enrollment of 850 patients in its pivotal Phase …
Hanover Bancorp (HNVR): Fourthstone group discloses 2.02% passive stake
Fourthstone LLC and related entities have disclosed a passive 2.02% stake in Hanover Bancorp (HNVR), representing 144,216 shares of common stock. This ownership, held on behalf of advisory clients, is based on 7,156,661 shares outstanding as of April 30, 2026. The group confirms the …
Terra Innovatum Global (NKLR) widens loss, carries $115.5M deficit and large contingent liabilities
Terra Innovatum Global (NKLR), a pre-revenue developer of the SOLO micro-modular nuclear reactor, reported a significantly widened net loss of $25.2 million for the first half of 2026, up from $2.6 million in 2025. The company also disclosed a substantial shareholders' deficit of $115.5 …
INNOVATE Corp. (VATE) interim CEO Paul Voigt reports 7.4% ownership
INNOVATE Corp.'s interim CEO, Paul Voigt, has reported beneficial ownership of 1,031,295 shares of common stock, representing 7.4% of the company. This includes shares held directly, through a revocable trust, and an LLC, as well as 300,000 shares issuable upon the exercise of stock …
ANVS: Net loss rose sharply as clinical trial costs surged, with cash runway only through Q4 2026
Annovis Bio (ANVS) reported a significant widening of its net loss to $14.8M for Q2 2026 and $32.4M for the first half, primarily due to increased R&D and G&A expenses as late-stage clinical trials advanced. The company's current cash of $18.7M is projected to …
ANVS: Alzheimer's Phase 3 trial fully enrolled; R&D costs and net loss per share increased year-over-year
Annovis Bio (ANVS) has fully enrolled its pivotal Alzheimer's Phase 3 trial, with topline data anticipated in Q1 2027. The company experienced a sharp increase in research and development expenses, leading to a higher net loss per share year-over-year. Additionally, enrollment continues for the …
Rubric Capital discloses 3.9M-share Enovis (ENOV) position in Schedule 13G
Rubric Capital Management LP and David Rosen have jointly filed a Schedule 13G, disclosing beneficial ownership of 3,900,000 shares of Enovis Corporation (ENOV) common stock. This position represents 6.78% of the company's outstanding shares, based on 57,562,603 shares as of May 1, 2026. Both …
Bank of America Revamps Lenovo Stock Price Target for 2026
This article first appeared on GuruFocus. Bank of America upgraded Lenovo (LNVGF) (LNVGY) to Buy from Neutral after a blowout fiscal first quarter, arguing that a sharp acceleration in servers is changing the earnings profile of a company still widely associated with PCs. The …
Sharemaestro market context Trend signal active 52 weeks +215.9%SS Innovations International (SSII) Reports Record Q2 Revenue of $13.9M, Up 39.4%
SS Innovations International (SSII) announced record second-quarter 2026 revenue of $13.9 million, a 39.4% increase year-over-year, driven by a 30.4% rise in SSi Mantra surgical robotic system installations. The company reported a gross profit of $7.1 million and a cumulative installed base of 224 …
Nova (NVMI) Is Up 7.9% After Strong Q2 Beat And Confident Q3 Guidance – What's Changed
Nova Ltd. (NVMI) reported strong Q2 2026 results with increased revenue and net income, alongside confident Q3 guidance. This performance reinforces management's belief in current semiconductor process-control demand, despite potential risks from concentrated customer orders. The article highlights Nova's narrative projecting significant revenue and …
Innovative Eyewear Inc Q2 2026: Revenue $1.01M, EPS $(0.26) — 10-Q Summary
Innovative Eyewear Inc (LUCY) reported Q2 2026 results showing a significant revenue increase to $1.01M, a 74% year-over-year rise, driven by strong unit volume and expanded retail presence. The company also narrowed its net loss to $1.67M from $2.11M in Q2 2025, with diluted …
Novavax Inc. stock underperforms Friday when compared to competitors
Novavax Inc. (NVAX) shares dropped 1.11% on Friday, closing at $8.05, despite a three-day winning streak being snapped. This underperformance occurred on a negative trading day for the broader market, with both the NASDAQ Composite and Dow Jones Industrial Average also experiencing declines.
Fortune Brands Innovations Inc. stock underperforms Friday when compared to competitors
Fortune Brands Innovations Inc. (FBIN) stock fell 1.22% on Friday, closing at $47.84. This underperformance occurred during a generally negative trading session where both the S&P 500 Index and the Dow Jones Industrial Average also declined. It marked the third consecutive day of losses …
3 Reasons Why Growth Investors Shouldn't Overlook Enova International (ENVA)
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all. In addition to volatility, these stocks carry above-average …
Innovative Eyewear (LUCY) grows revenue 74% but stays unprofitable in Q2 2026
Innovative Eyewear, Inc. (LUCY) reported a 74% increase in revenue for Q2 2026, reaching $1,010,519, primarily driven by strong sales of Lucyd Armor smart safety glasses and Reebok-branded smartglasses. Despite the significant revenue growth and improved gross margin of 24%, the company continued to …
Innovative Eyewear Reports 74% Revenue Growth in Q2
Innovative Eyewear reported a significant 74% year-over-year revenue growth in Q2 2026, reaching over $1 million for the first time. The company also improved its gross margin to 24% and reduced operating expenses, demonstrating effective cost management. With strategic initiatives and partnerships, Innovative Eyewear …
Cenovus Energy Inc. stock rises Friday, outperforms market
Cenovus Energy Inc. (CVE) shares rose 1.01% on Friday to C$43.11, outperforming the broader Canadian market. The S&P/TSX Composite Index fell 0.08%, while Cenovus Energy Inc. closed 2.3% below its 52-week high. The company's stock reached its 52-week high of C$44.13 on May 20th.
Highbridge Capital (ANVS) discloses 6.1% Annovis Bio stake tied to 2.78M warrant shares
Highbridge Capital Management, LLC has disclosed a beneficial ownership of 6.1% in Annovis Bio, Inc., which is tied to 2,775,578 shares of common stock issuable upon the exercise of warrants. This stake is calculated based on 42,541,868 outstanding common shares after a referenced offering …
Will Bank of Nova Scotia (BNS) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Bank of Nova Scotia (BNS). This company, which is in …
Sharemaestro market context Trend signal active 52 weeks +64.9% · Next-week setup positive 64.3%Enova International (NYSE:ENVA) Hits New 52-Week High - Should You Buy?
Enova International (NYSE:ENVA) recently hit a new 52-week high of $266.99, with a market capitalization of $6.6 billion. The company surpassed quarterly expectations, reporting $4.31 EPS and $928.93 million in revenue, up 21.6% year-over-year. Despite a consensus "Buy" rating from analysts, some insider selling …
Should Investors Take Profits in GE Vernova After Its Big Run?
GE Vernova stock has surged 674% since its spinoff, driven by massive demand for its power equipment from AI data centers, leading to a $176 billion backlog. While its valuation is high, reflecting strong growth prospects, early investors might consider taking some profits to …
Sharemaestro market context Trend signal active 52 weeks +59.9%Annovis Bio Sees Unusually Large Options Volume (NYSE:ANVS)
Annovis Bio (NYSE:ANVS) experienced unusual options trading volume on Friday, with traders buying 3,595 put options, a 139% increase over its typical daily volume. Despite a "Moderate Buy" consensus rating from analysts, the stock is trading near its 52-week low. The company recently reported …
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Inovio Pharmaceuticals Inc. (INO) shares surged 21.10% to $1.09 on Friday, outperforming the broader market as the NASDAQ Composite Index and Dow Jones Industrial Average both experienced declines. This marked the fifth consecutive day of gains for Inovio's stock, despite a generally rough trading …
Sharemaestro market context Price below Trend Line 52 weeks -64.8% · Next-week setup negative 34.0%SS Innovations International (NASDAQ: SSII) Reports Record Q2 Revenue of $13.9M, Up 39.4%
SS Innovations International (SSII) announced record second-quarter 2026 revenue of $13.9 million, a 39.4% increase year-over-year, driven by a 30.4% rise in SSi Mantra surgical robotic system installations. The company reported a gross profit of $7.1 million and a cumulative installed base of 224 …
T. Rowe Price Associates (THG) discloses 5.2% Hanover Insurance ownership stake
T. Rowe Price Associates, Inc. has reported a 5.2% beneficial ownership stake in Hanover Insurance Group Inc., holding 1,831,584 shares. The firm exercises sole voting power over 1,819,788 shares and sole dispositive power over all 1,831,584 shares. T. Rowe Price Associates explicitly denies that …
T. Rowe Price (NOVT) discloses 6.2% beneficial stake in Novanta common stock
T. Rowe Price Associates, Inc. has disclosed a 6.2% beneficial ownership stake in Novanta Inc. (NOVN), amounting to 2,222,444 shares of common stock. The firm reported sole voting power over 2,216,715 shares and sole dispositive power over all 2,222,444 shares, while explicitly denying that …